InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
+10.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Thorp Clay, Director. Director active across 4 companies, notably PhaseBio Pharmaceuticals Inc. Aggregated, 10 reports have been logged. Breakdown: 6 buys · 1 sell. Total volume traded: €258k. History available since 18 August 2021. The latest transaction was filed on 24 February 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Thorp Clay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
15,000 shares@ US$0.928.5% of flowCommon StockSEC:0001415889-25-005325:0
Canonical exit: 25 May 2025 (T+90)
10,000 shares@ US$0.865.7% of flowCommon StockSEC:0001209191-23-050480:0
Canonical exit: 24 Dec 2023 (T+90)
3,750 sharesCommon StockSEC:0001169245-23-000032:0
14,000 shares@ US$1.0198.7% of flowCommon StockSEC:0001209191-22-062338:0
Canonical exit: 21 Mar 2023 (T+90)
32,873 shares@ US$4.4377.6% of flowCommon StockSEC:0001209191-22-062044:0
1,406,507 shares0Common StockSEC:0001209191-22-062045:0
21,802 shares@ US$2.762274.6% of flowCommon StockSEC:0000899243-22-018491:0
Canonical exit: 14 Aug 2022 (T+90)
3,000 shares@ US$7.201425.4% of flowCommon StockSEC:0000899243-22-012485:0
Canonical exit: 26 Jun 2022 (T+90)
1,254,335 sharesCommon StockSEC:0000899243-22-001658:0
10,000 shares@ US$3.00100.0% of flowCommon StockSEC:0001169245-21-000080:0
Canonical exit: 16 Nov 2021 (T+90)
10 of 10 declarations
About Thorp Clay
Thorp Clay is Administrateur and serves as a director at Clearside Biomedical, Inc., Vigil Neuroscience, Inc. and PhaseBio Pharmaceuticals Inc. He has 10 filings in total, and in the recent filings we hold, the transactions run from 2021-08-18 to 2025-02-24, with EUR 137693 of purchases and EUR 120155 of sales; the modal transaction nature is Acquisition.
